Go to the list of all blogs
John Y White's Avatar
published in Blogs
Jul 31, 2026
Why Is AXT, Inc. (AXTI) Stock Up +24.76% Today?

Why Is AXT, Inc. (AXTI) Stock Up +24.76% Today?

Key Takeaways

  • AXTI shares surged 24.76% in Friday's trading session, reaching $58.56 after closing at $46.94 the previous day, extending a powerful two-day rally.
  • The primary catalyst was a blowout Q2 2026 earnings report released after Thursday's close, in which AXT delivered record revenue of $47.6 million and swung to a non-GAAP profit of $0.19 per share, crushing consensus estimates.
  • Q3 guidance far exceeded Wall Street expectations, with management forecasting EPS of $0.30–$0.32 on revenue of approximately $66 million, compared to analyst estimates of $0.10 and $38.7 million respectively.
  • Record indium phosphide (InP) revenue of $30.7 million, driven by surging demand for AI data center optical connectivity, underscored the company's strategic position in the semiconductor substrate supply chain.
  • Long-term supply agreements with Lumentum, Coherent, and Casela — along with a backlog exceeding $100 million — provided additional confidence in AXT's multi-year growth trajectory.
  • Traders are now watching for further updates on export permit timelines, capacity expansion milestones, and the planned Hong Kong listing of subsidiary Tongmei.

Opening Summary

AXTI — AXT, Inc., a Fremont, California-based global supplier of compound and single-element semiconductor substrates — saw its shares rocket higher by 24.76% on Friday, continuing a powerful rally sparked by the company's second-quarter 2026 earnings release. After closing Thursday's regular session at $46.94 — already up nearly 27% on the day — the stock extended its gains in Friday trading to reach $58.56. The dramatic move reflects overwhelming investor enthusiasm following quarterly results that not only shattered expectations but also included forward guidance that signals a fundamental inflection point for the business.

Earnings Blowout: Q2 Results Crush Consensus

AXT reported second-quarter revenue of $47.6 million, a record for the company, representing a 164% surge from the $18.0 million reported in the same quarter a year ago and a 77% sequential increase from Q1 2026. The result demolished the Wall Street consensus estimate of approximately $34.1 million. Non-GAAP earnings per share came in at $0.19, an extraordinary outperformance compared to the $0.07 consensus — a beat of roughly 171% — and a dramatic turnaround from a loss of $0.15 per share in the year-ago period.

The standout performer was indium phosphide (InP), which generated record quarterly revenue of $30.7 million, driven primarily by demand for data center optical connectivity applications. Non-GAAP gross margin expanded sharply to 45.0%, up from 29.9% in the prior quarter and just 8.2% a year ago, reflecting higher volumes and a favorable product mix as the company scaled production. CEO Morris Young declared that AXT has reached "an inflection point," crediting strong customer demand and improved manufacturing productivity for a "step-function increase" in revenue.

Blockbuster Guidance Signals Sustained Momentum

If the Q2 results ignited the rally, the third-quarter guidance poured fuel on the fire. AXT projected Q3 non-GAAP EPS of $0.30 to $0.32 — triple the $0.10 analyst consensus — on revenue of approximately $66 million, nearly 70% above the $38.7 million Street estimate. Management noted that the $66 million figure represents revenue for which the company already holds export permits or does not require them, providing a high degree of confidence. Executives further indicated potential for "significant upside" should additional export permits be granted for other orders already backed by inventory.

The guidance reflects not just a one-time surge but what management characterized as a new, structurally higher revenue run-rate, underpinned by accelerating deployment of optical connectivity as hyperscale data center operators migrate to higher-speed transceiver modules.

Strategic Supply Deals Lock In Long-Term Demand

Adding to the bullish narrative, AXT has secured a series of high-profile, multi-year supply agreements that bolster revenue visibility well into 2027 and beyond. On July 29, the company announced a long-term agreement with LITE — Lumentum Operations — to supply indium phosphide wafer substrates with reserved production capacity in exchange for prepayments. This followed earlier deals with COHR — Coherent Corp., which agreed to a $25.4 million prepayment — and Casela Technologies, which provided $22.3 million in upfront cash to secure capacity. Combined with an InP backlog that management described as "well over $100 million" and still growing, AXT's demand pipeline extends far beyond its current production capability.

Market Context and Trading Activity

Friday's surge occurred on exceptionally heavy volume, continuing the pattern from Thursday when more than 8.7 million shares changed hands versus a daily average of roughly 10 million. The move extended AXT's extraordinary year-to-date performance; even before this week's earnings-driven breakout, the stock had already rallied more than 150% in 2026, fueled by investor conviction that AI infrastructure spending would directly benefit upstream semiconductor material suppliers.

The broader semiconductor sector traded positively on Friday, but AXT's gains far outpaced both the SMH semiconductor ETF and the SOXX iShares Semiconductor ETF, underscoring the stock-specific nature of the catalyst. The rally pushed shares decisively above prior near-term resistance levels and through the psychologically important $50 threshold, though the stock remains well below its 52-week high of $143.16.

What Comes Next for AXTI

AXT enters the second half of 2026 with enormous tailwinds but also notable uncertainties. The company is racing to expand its indium phosphide production capacity, targeting quarterly capacity of roughly $60 million by year-end 2026 and approximately $130 million by end of 2027. Execution on these expansion plans will be critical, as demand continues to outstrip supply.

Export permit dynamics remain a key risk factor. A significant portion of AXT's revenue flows through its China-based subsidiary, and U.S.-China technology export controls introduce ongoing regulatory uncertainty. The planned shift of subsidiary Tongmei's IPO from Shanghai's STAR Market to the Hong Kong Exchange — a process expected to take approximately one year — adds another layer of complexity. Additionally, heavy insider selling in recent months, including by CEO Morris Young, may raise questions about valuation even as the fundamental story improves dramatically. Analyst opinions remain divided, with price targets ranging from $52 to $125, reflecting the wide dispersion of views on the durability of AXT's growth trajectory.

Trending AI Robots

For investors seeking systematic, data-driven approaches to navigating volatile markets, Tickeron's Trending AI Robots page offers a curated selection of top-performing AI trading bots. Tickeron provides hundreds of AI-powered trading bots spanning thousands of tickers, but only those demonstrating the strongest performance under current market conditions are featured in this dynamic, regularly updated section. Bots vary by trading strategy, timeframe, performance metrics, and the symbols they trade, allowing users to identify approaches aligned with their own investment style. Explore the Trending AI Robots page to discover which automated strategies are currently leading the pack.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: AXTI

AXTI's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for AXTI turned positive on July 21, 2026. Looking at past instances where AXTI's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where AXTI's RSI Indicator exited the oversold zone, of 34 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The Momentum Indicator moved above the 0 level on July 30, 2026. You may want to consider a long position or call options on AXTI as a result. In of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where AXTI advanced for three days, in of 280 cases, the price rose further within the following month. The odds of a continued upward trend are .

AXTI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AXTI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for AXTI entered a downward trend on July 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AXTI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (11.312) is normal, around the industry mean (8.241). AXTI has a moderately low P/E Ratio (0.000) as compared to the industry average of (79.148). AXTI's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.535). AXTI has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.006). P/S Ratio (22.676) is also within normal values, averaging (95.043).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AXTI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 67, placing this stock worse than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are Applied Materials (NASDAQ:AMAT), Lam Research Corp (NASDAQ:LRCX), KLA Corporation (NASDAQ:KLAC), Teradyne (NASDAQ:TER), Ambarella (NASDAQ:AMBA).

Industry description

The electronic production equipment industry makes equipment used to produce semiconductors. Such equipment includes wafer fabrication, plasma etching and photo-resist processing equipment. The industry also makes chemical vapor deposition processing systems and photomasks, which are high-purity quartz plates that contain patterns to define integrated circuits layouts. Applied Materials, Inc., Lam Research Corporation, and KLA-Tencor Corporation are examples of electronic production equipment manufacturing companies.

Market Cap

The average market capitalization across the Electronic Production Equipment Industry is 61.03B. The market cap for tickers in the group ranges from 555.66K to 595.74B. ASML holds the highest valuation in this group at 595.74B. The lowest valued company is AVSR at 555.66K.

High and low price notable news

The average weekly price growth across all stocks in the Electronic Production Equipment Industry was -2%. For the same Industry, the average monthly price growth was -22%, and the average quarterly price growth was 44%. AMBA experienced the highest price growth at 5%, while AMKR experienced the biggest fall at -26%.

Volume

The average weekly volume growth across all stocks in the Electronic Production Equipment Industry was 126%. For the same stocks of the Industry, the average monthly volume growth was 2% and the average quarterly volume growth was -31%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 61
P/E Growth Rating: 37
Price Growth Rating: 54
SMR Rating: 75
Profit Risk Rating: 66
Seasonality Score: -19 (-100 ... +100)
View a ticker or compare two or three
AXTI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a manufactures of high-performance compound semiconductor substrates

Industry ElectronicProductionEquipment

Profile
Details
Industry
Electronic Production Equipment
Address
4281 Technology Drive
Phone
+1 510 438-4700
Employees
1075
Web
http://www.axt.com
Interact to see
Advertisement
The Travelers Companies, Inc.(TRV), a major player in the property and casualty insurance market, reported fourth-quarter 2025 results on January 21, 2026, closing out a year marked by underwriting discipline despite volatile weather activity and pricing pressures. The results underscore Travelers’ ability to generate strong profitability while navigating challenges in personal insurance lines and heightened catastrophe risk.
FingerMotion, Inc. (NASDAQ: FNGR) reported fiscal third-quarter 2026 results on January 15, 2026, triggering a sharp selloff as investors reacted to a steep revenue decline and widening losses. Shares fell roughly 32% following the release after the mobile services provider disclosed a 32% year-over-year drop in revenue and a net loss of $1.67 million for the quarter ended November 30, 2025.
CSX (NASDAQ: CSX) reports Q4 2025 earnings after market close on January 22, 2026, with consensus EPS ~$0.42 and revenue ~$3.57 billion. Union Pacific (NYSE: UNP) follows on January 27, with EPS expected near $2.89 and revenue around $6.15 billion. Norfolk Southern (NYSE: NSC) closes the week on January 29, with consensus EPS ~$2.77.
The SPDR S&P Aerospace & Defense ETF (XAR) has surged to a new 52-week high above $281 this week, climbing 21% month-to-date and 20% year-to-date through January 2026. The rally, driven by robust sector momentum and a clean technical breakout, is outpacing broader indices like the S&P 500. XAR’s equal-weighted structure amplifies gains from top aerospace and defense holdings in missiles, aircraft, and space systems, attracting significant trader and institutional attention amid heightened geopolitical tensions.
The iShares U.S. Aerospace & Defense ETF (ITA) continues to attract trader attention, building on a remarkable 47.7% gain in 2025 amid rising defense budgets and heightened global security concerns. The ETF is approaching all-time highs, with top holdings such as GE Aerospace and RTX Corporation driving the rally. Traders are adding positions on dips while monitoring confirmation above key resistance levels near recent peaks, anticipating a potential technical breakout.
Chevron’s upcoming Q4 report highlights its first full quarters integrating Hess, following record Q3 production of 4.1 million barrels of oil equivalent per day (MMboe/d). Comparing CVX with ExxonMobil and Shell provides insight into how each supermajor is navigating a volatile oil market with prices hovering below $60 per barrel.
SoFi Technologies is set to report Q4 and full-year 2025 earnings on January 30, 2026, closing out a pivotal year for the digital finance platform. With its fiscal year ending December 31, the report follows a strong Q3 that featured record net revenue of $962 million and member growth to 12.6 million, a 35% year-over-year increase.
ASML reported Q4 2025 net sales of $9.7 billion, gross margin of 52.2%, net income of $2.8 billion, and record net bookings of $13.2 billion, including $7.4 billion in EUV orders.
IDEXX Laboratories (IDXX) reports Q4 2025 earnings on February 2, 2026, with analysts expecting continued strength in recurring revenue from companion animal diagnostics. Danaher (DHR) reports on January 28, while Thermo Fisher Scientific (TMO) follows in early February, with both facing low-single-digit core growth expectations across life sciences and diagnostics.
NIO Inc. (NIO) produced its one-millionth vehicle this week at its Hefei facility, closing out a record 2025 delivery total of 326,028 units, up 46.9% year over year. The milestone, announced January 6, reflects accelerating demand for core models such as the ES8 SUV and newer brands ONVO and Firefly.
Faraday Future Intelligent Electric Inc. (FFAI) shares traded near $1.02 this week following announcements of a non-binding $10 million stock purchase term sheet with AIxCrypto (AIxC) and preparations for a Stockholders’ Day on January 7, 2026. Trading volume spiked amid broader EV volatility, highlighting investor attention on FFAI’s pivot toward AI-enhanced mobility and robotics.
BTQ Technologies Corp. (BTQ), formerly BTQQF, launched the Bitcoin Quantum testnet this week—the first quantum-safe Bitcoin fork, 17 years after Bitcoin’s genesis block. The move coincided with inclusion in the $524.5 million VanEck Quantum Computing UCITS ETF, boosting European investor visibility.
VEU targets large- and mid-cap ex-U.S. stocks with ~3,800 holdings. VXUS offers broad all-cap exposure, including ~8,600 stocks across small-, mid-, and large-cap companies.
Apple (AAPL) reports Q1 FY2026 earnings on January 29, with consensus revenue at $138.5B and EPS at $2.67, supported by strong demand for iPhone 17 models, higher average selling prices, and continued Services growth. Microsoft (MSFT) reports Q2 FY2026 on January 28, expecting $80.3B revenue and $3.91 EPS, driven by Azure AI adoption and enterprise cloud expansion, though elevated capex spending (~$35B/quarter) remains under scrutiny.
Visa Inc. (V), the global payments network leader, reports Q1 FY2026 earnings on January 29, 2026, for the period ending December 31, 2025. This marks the start of FY2026 following a strong FY2025, where net revenue reached $40 billion (+11%) and EPS climbed to $11.47 (+14%). Investors are watching closely for insights into consumer spending, cross-border travel recovery, and digital payment adoption.
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.